Literature DB >> 33991506

Inhaled budesonide for early treatment of COVID-19.

Markus Zeitlinger1, Marco Idzko2.   

Abstract

Entities:  

Year:  2021        PMID： 33991506     DOI： 10.1016/S2213-2600(21)00215-0

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis.

Authors:  Anselm Jorda; Manuel Kussmann; Nebu Kolenchery; Jolanta M Siller-Matula; Markus Zeitlinger; Bernd Jilma; Georg Gelbenegger
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

2.  Anticoagulant Treatment Regimens in Patients With Covid-19: A Meta-Analysis.

Authors:  Anselm Jorda; Jolanta M Siller-Matula; Markus Zeitlinger; Bernd Jilma; Georg Gelbenegger
Journal:  Clin Pharmacol Ther       Date:  2021-12-19       Impact factor: 6.903
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.